Pharmaceutical Company Announces Monkey Pox Vaccine Development: Stock Surges
TNXP is developing a vaccine candidate, called TNX-801, that could play a role in combating this escalating global health crisis.
Disclaimer: The following article is intended for informational purposes only and should not be considered as investment advice or an endorsement of any medical product. Readers are encouraged to conduct their own research and consult with professional advisors.
We are working endlessly to provide free insights on the stock market…